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Cryopreservation of ovarian tissue may be a potential alternative for the conservation of 
genetically superior animals, including high milk- and meat-producing goat breeds. However, 
until now, no information was available concerning the cryopreservation of preantral follicles 
(PF) enclosed in caprine ovarian tissue. The objective of the present study was to evaluate the 
structural and ultrastructural characteristics of caprine PF after exposure to and 
cryopreservation of ovarian tissue in 1.5 and 3 M glycerol (GLY) and ethylene glycol (EG). At 
the slaughterhouse, each ovarian pair from five adult mixed breed goats was divided into nine 
fragments and randomly distributed into treatment groups. One fragment was immediately 
fixed for histological examination and ultrastructural analysis, after slaughter (control). Four of 
the ovarian fragments were equilibrated at 20 °C for 20 min in 1.8 ml of MEM containing 1.5 or 
3 M GLY or EG for a toxicity test and the final four fragments were slowly frozen using these 
cryoprotectants at the concentrations above. After toxicity testing and freezing/thawing, the 
ovarian fragments were fixed for histological examination. Histological analysis showed that 
after toxicity testing and cryopreservation of the ovarian tissue in GLY or EG at both 
concentrations, the percentage of normal PF was significantly lower than controls. 
Ultrastructural analysis of PF frozen in 1.5 and 3 M GLY, as well as 3 M EG demonstrated that 
these follicles remained morphologically normal. In conclusion, we demonstrated 
cryopreservation of caprine PF in ovarian tissue. 
 





In an attempt to protect biodiversity and to assure the preservation of a species, 
cryotechnology has been extensively used for male and female gamete conservation; this has 
allowed the development of germplasm banks of valuable animal stocks and endangered 
species. Several studies have reported successful cryopreservation of metaphase II oocytes [1], 
[2], [3] and [4]. However, it is well known that in metaphase II oocytes, the chromosomes are 
aligned along a delicate spindle of microtubules that are sensitive to cooling and the 
cryoprotective solutions [5] usually used in cryopreservation protocols. 
It has been suggested that preservation of female gametes may be better achieved by 
storing pieces of ovarian tissue, containing numerous immature small oocytes enclosed in 
preantral follicles (PF) [6]. These oocytes are less differentiated, possess fewer organelles, lack 
a zona pellucida and cortical granules, and are less active metabolically. All these 
characteristics are potentially beneficial to the freezing/thawing process [7], [8] and [9]. 
Gosden et al. [10] demonstrated that the fertility of ovariectomized sheep can be restored 
after cryopreservation and transplantation of ovarian fragments containing immature oocytes 
enclosed in preantral follicles. Although there has been some success in ovarian tissue 
cryopreservation, several studies [11], [12], [13], [14] and [15] indicated that follicular damage 
occurs after freezing and thawing. Such damage can occur during any of step of the 
cryopreservation process (exposure of the tissue to the cryoprotectant, freezing or thawing). 
To improve the efficiency of this procedure, it is necessary to identify and to quantify oocyte 
losses at different stages of cryopreservation. 
Most protocols for ovarian tissue cryopreservation utilize permeable cryoprotectants 
at a concentration of 1.5 M and do not report the effect of other concentrations of 
cryoprotectant [15], [16] and [17]. Some authors [12] and [18] affirm that GLY is less 
permeable than other cryoprotectan such as EG, and consequently, not suitable for the 
cryopreservation of ovarian tissue. However, none of the cryoprotectants noted have been 
tested on caprine ovarian tissue. Moreover, most reports are based on histological findings 
[17], [19], [20], [21], [22], [23] and [24], that are less reliable than transmission electron 
microscopy (TEM). Therefore, the objective of this study was to evaluate the structural and 
ultrastructural characteristics of caprine preantral follicles after exposure and cryopreservation 
of the ovarian tissue in GLY and EG at concentrations of 1.5 and 3 M. 
2. Materials and methods 
2.1. Source and preparation of ovarian tissue 
Caprine ovaries (n=10) from adult mixed breed goats (n=5) were obtained at a local 
abbatoir. The ovaries were trimmed, and washed in 70% alcohol and then in phosphate 
buffered saline (PBS). Subsequently, the ovarian pair from each animal was divided into nine 
fragments of approximately 3-mm thickness ( Fig. 1). For fresh controls (Treatment 1: T1), one 
ovarian fragment was taken randomly and immediately fixed for 24 h in Trump McDowell 
fixative solution (TMFS) for histological examination. From this fragment, a small piece was 
taken and fixed in a paraformaldeyde/glutaraldeyde solution (2% paraformaldeyde and 2.5% 
glutaraldeyde in 0.1 M cacodylate buffer, pH 7.2) for TEM. The other eight fragments were 
transported to the laboratory within 1 h in PBS at 20 °C and submitted to toxicity testing (n=4) 
or freezing–thawing (n=4), as described in the following section. 
 
Fig. 1. Experimental design for toxicity testing and cryopreservation of goat preantral follicles enclosed 
in ovarian tissue. 
 
2.2. Toxicity test 
 
The toxicity test was performed to evaluate the effect of the exposure of ovarian tissue 
to glycerol (GLY) or ethylene glycol (EG), without freezing, on the percentage of normal 
follicles. For this test, ovarian fragments (n=4) were exposed for 20 min at 20 °C (equilibration 
period) in 1.8 ml of MEM with GLY or EG, both at 1.5 or 3 M (T2–T5). After the equilibration 
period, cryoprotectants were immediately removed from the tissue according to the method 
described by Candy et al. [12]. The fragments were washed three times for 5 min in minimum 
essential medium (MEM) supplemented with 10% fetal bovine serum (FBS-MEM+) at room 
temperature. Finally, the ovarian fragments were fixed in TMFS for histological examination. 
 
2.3. Freezing and thawing procedures 
 
For freezing, ovarian fragments (n=4) were placed individually in 2.0 ml vials and 
equilibrated in 1.8 ml MEM+ with cryoprotectants (GLY or EG) at the concentrations and 
equilibration period used in the toxicity test (T6–T9). After the equilibration period, the vials 
containing the ovarian tissue were transferred to a biological programmable freezer (Freeze 
Control, CryoLogic Pty Ltd., Waverley, Australia) at 20 °C. The vials were cooled at 2 °C/min to 
−7 °C and ice crystal formation (seeding) was induced manually by touching the vials with 
forceps pre-chilled in liquid nitrogen. The specimens were held at this temperature for 15 min, 
then cooled at 0.3 °C/min to −30 °C and thereafter at 0.15 °C/min to −33 °C. The vials were 
plunged directly into liquid nitrogen (−196 °C) and stored for up to 5 days before thawing. The 
freezing curve used in this study was chosen because most procedures currently used to 
cryopreserve oocytes [25], [26], [27], [28], [29] and [30] and ovarian tissue [10], [11], [12], [14], 
[15], [18], [24], [31], [32] and [33] stipulate a cooling rate of 0.3–0.5 °C/min from the seeding 
temperature (usually −5 to −9 °C) to a lower temperature, usually between −30 and −40 °C. 
For thawing, the vials were taken from the liquid nitrogen, warmed rapidly at room 
temperature for 1 min and immersed in water bath at 37 °C until the ice melted. The 
cryoprotectant was then removed as described above for toxicity testing and fixed for 
histological examination and TEM. Each treatment was repeated five times. 
 
2.4. Histological analysis 
 
Ovarian tissue from all treatments was fixed in TMFS for 24 h to evaluate the quality of 
goat preantral follicles inside the ovarian tissue. After fixation, fragments were dehydrated, 
diafanized and embedded in paraffin wax. Serial sections (7 μm) of ovarian tissue were cut and 
every fifth section was mounted on glass slides and stained with periodic acid Schiff (PAS)-
hematoxylin. All sections were examined using a light microscope at magnifications 20× and 
40×. Thirty preantral follicles in each replicate were evaluated per treatment (T1–T9). Preantral 
follicles were classified as either an oocyte surrounded by one flattened and/or cuboidal layer 
or several layers of only cuboidal granulosa cells. To avoid counting a follicle more than once, 
preantral follicles were counted only in the sections where the oocyte nuclei were seen. 
Follicular quality was evaluated based on morphological features such as integrity of the 
oocyte, granulosa cells and basement membrane. Preantral follicles were classified as 
morphologically normal (preantral follicles containing an intact oocyte and granulosa cells 
without pyknotic nuclei), degenerated Grade 1 follicles (preantral follicles characterized by 
pyknosis of the oocyte nucleus) and degenerated Grade 2 (preantral follicles characterized by 
oocyte nucleus pyknosis plus oocyte shrinkage, with or without detachment of granulosa cells 




2.5. Ultrastructural analysis 
 
For a better evaluation of follicular morphology, ultrastructural analysis was performed 
using ovarian fragments from control groups and cryopreservation treatments. Tissue 
fragments with a maximum dimension of 1 mm3 were fixed in 2% paraformaldeyde and 2% 
glutaraldeyde in 0.1 M sodium cacodylate buffer (pH 7.2) for 3 h. After fixation and several 
washes, specimens were post-fixed in 1% osmium tetroxide, 0.8% potassium ferricyanide and 
5 mM calcium chloride in 0.1 M sodium cacodylate buffer for 1 h. Subsequently, the samples 
were dehydrated through a gradient of acetone solutions and the tissues were embedded in 
Spurr. Semi-thin sections (3 μm) were stained with toluidine blue. The ultra-thin sections (60–
70 nm) were cut and stained with uranyl acetate and lead citrate, and examined under a Jeol 
JEM 100 C transmission electron microscope. 
 
2.6. Statistical analysis 
 
The effect of type (GLY and EG) and concentration (1.5 and 3 M) of cryoprotectant on 
the percentage of normal and degenerated Grades 1 and 2 preantral follicles were analyzed by 




3.1. Morphological aspects of normal and degenerated Grades 1 and 2 preantral 
follicles 
A total of 1350 preantral follicles were examined in the five replicates. Histological 
analysis of the ovarian tissue indicated that normal (Fig. 2A) and degenerated Grade 1 (Fig. 2B) 
and Grade 2 follicles (Fig. 2C) were found in controls as well as after toxicity testing and 
cryopreservation. Combined for all data, the distribution of normal and degenerated Grades 1 
and 2 preantral follicles was 89, 4, and 7% for control, 52, 6 and 42% for toxicity test, and 39, 
15 and 46% for cryopreservation, respectively. Of the total degenerated follicles (especially 
related to the oocyte compartment), 14% had only nuclear pyknosis and 16% had oocyte 
shrinkage associated with nuclear pyknosis. Considering both compartments (oocyte and 
granulosa cells), 63% of the follicles had pyknosis in the oocyte nucleus plus oocyte shrinkage 
and detachment of granulosa cells from the basement membrane, 2% detachment of 
granulosa cells from the basement membrane accompanied by oocyte shrinkage, and 5% 
detachment of granulosa cells from the basement membrane, accompanied by pyknosis in the 
oocyte nucleus. The major finding observed by ultrastructural analysis of degenerated follicles 
was an intense vacuolization in the oocyte cytoplasm and loss of granulosa cell contents. 
 
Fig. 2. Histological sections of goat normal (A) and degenerated Grade 1 (B) and degenerated Grade 2 (C) 
preantral follicles after cryopreservation (magnification: 400×). O: normal oocyte; NU: nucleus of normal 




3.2. Percentage of normal preantral follicles after toxicity testing and 
cryopreservation 
 
The percentage of normal preantral follicles analyzed by histological analysis in 
controls as well as after toxicity testing and cryopreservation is shown in Table 1. Exposure to 
GLY or EG in both concentrations (toxicity testing) reduced (P<0.05) the percentage of normal 
preantral follicles compared to controls. For both cryoprotectants, the percentage of normal 
follicles was lower (P<0.05) for hen 3 M versus 1.5 M. When the cryoprotectants were 
compared to each other at the same concentration, the percentage of normal follicles was 
higher (P<0.05) in EG than GLY for both concentrations. When both cryoprotectants were 
compared between the different concentrations, the percentage of normal preantral follicles 
was higher (P<0.05) in 1.5 M EG compared to 3 M GLY. However, in 3 M EG, the percentage of 
normal preantral follicles was similar to that observed in 1.5 M GLY ( Table 2). 
 
Table 1 
Normal preantral follicles (%) in control, after toxicity testing and cryopreservation, as 
determined by histological evaluation 
 
Values within rows (a, b, c) are different (P < 0:05). 
Values within columns (d, e) are different (P < 0:05). * 
P < 0:05, significantly differs from control 
 
Table 2. 
Grades 1 and 2 preantral follicles (%) in controls, after toxicity testing and cryopreservation 
 
Different superscripts (a, b, c) differ significantly at the same cryoprotectant and same concentration. 
Different superscripts (d, e) differ significantly between Grades 1 and 2 degeneration. 
Different superscripts (f, g) differ significantly between toxicity test and cryopreservation. * 
P < 0:05, significantly differs from control 
 
After freezing and thawing, the percentage of normal follicles was lower (P<0.05) than 
in fresh ovarian tissue (controls). After cryopreservation, the percentage of normal preantral 
follicles did not differ among treatments, except for 3 M EG, which had a significantly higher 
percentage of normal follicles than 1.5 M EG. 
When comparisons were made between toxicity testing and cryopreservation using 
the same cryoprotectants and concentrations, in 1.5 M EG the percentage of normal preantral 
follicles was lower (P<0.05) after freezing and thawing when compared to toxicity testing. 
 
3.3. Distribution of follicular degeneration grade in controls, after toxicity testing and 
cryopreservation 
 
Fig. 3 shows the distribution of degenerated Grades 1 and 2 preantral follicles in 
controls and after toxicity testing and cryopreservation. The percentage of degenerated Grade 
1 follicles in controls was lower (P<0.05) than in 3 M EG after toxicity testing and 1.5 M GLY 
and EG after cryopreservation. After toxicity testing and cryopreservation, the percentage of 
degenerated Grade 2 follicles treatments was higher (P<0.05) than the controls. There was no 
significant difference between percentages of degenerated Grades 1 and 2 follicles in controls. 
 
Fig. 3. Electron micrograph of a follicle from control group. O: oocyte, GC: granulosa cells, Nu: nucleus, 
m: mitochondria, er: endoplasmic reticulum, v: vesicles (magnification: 3400×). 
 
Exposure of ovarian tissue to 1.5 M EG (toxicity testing) had a lower percentage 
(P<0.05) of degenerated Grades 1 and 2 follicles when compared to 3 M. The percentage of 
Grade 2 degeneration was higher (P<0.05) in GLY than in EG at both concentrations. With 
regard to the distribution of follicular degeneration grades for each treatment, for both 
cryoprotectants and concentrations, the percentage of degenerated Grade 2 follicles was 
higher (P<0.05) than degenerated Grade 1 follicles. 
In contrast to observations in the toxicity test, after cryopreservation with 1.5 M EG, a 
greater percentage (P<0.05) of degenerated Grade 1 follicles was found in 3 M EG, as well as in 
1.5 M GLY. Regarding Grade 2 degeneration, when the concentrations were compared to each 
other in the cryoprotectant, no significant difference was observed. The percentage of Grade 2 
follicles was higher (P<0.05) when compared to Grade 1 follicles in all treatments for both 
cryoprotectants and concentrations, except for 1.5 M EG. 
When comparisons were made between toxicity testing and cryopreservation in the 
same cryoprotectant and concentration, in 1.5 M GLY and EG, the percentage of degenerated 
Grade 1 follicles in the toxicity test was lower (P<0.05) than after cryopreservation. Similar 
results were also observed in degenerated Grade 2 follicles in 1.5 and 3 M EG. 
 
3.4. Ultrastructural analysis of the ovarian tissue 
 
Only preantral follicles from controls (Fig. 3) and those frozen in 1.5 and 3 M GLY (Fig. 
4A and B), as well as 3 M EG (Fig. 4D) appeared morphologically normal after ultrastructural 
analysis. These follicles exhibited a large number of mitochondria and some vesicles 
distributed through the ooplasm. Transmission electron microscopy revealed that follicles 
from ovarian tissue frozen at 1.5 M EG considered normal at histological analysis (Fig. 4C) were 
extremely vacuolated. In some cases, the fusion of these vacuoles produced an empty area. 
Sometimes this alteration was associated with the loss of granulosa cell content and, in some 
cases, with oocyte nucleus shrinkage (data not shown). In order to verify that the deleterious 
effect of 1.5 M EG occurred in toxicity testing, ultrastructural analysis was also performed in 
the ovarian tissue from this treatment. The ultrastructure of normal preantral follicles in the 
ovarian tissue exposed to 1.5 M EG was similar to controls, indicating that the ultrastructural 
change occurred during the cryopreservation process. 
 Fig. 4. Electron micrographs of follicle cryopreserved with (A) 1.5 M glycerol, (B) 3 M glycerol, 
(C) 1.5 M ethylene glycol, and (D) 3 M ethylene glycol. O: oocyte, GC: granulosa cells, Nu: 




The present study was the first report of toxicity testing and cryopreservation in GLY 
and EG of caprine preantral follicles enclosed in ovarian tissue. Although degenerated follicles 
were observed during exposure to cryoprotectants and after freezing and thawing, a normal 
morphologic appearance was maintained in 31% (EG: 1.5 M) to 47% (EG: 3 M) of the preantral 
follicle population after freezing and thawing. Normal follicles obtained after freezing/thawing 
indicated that the morphology was similar to that observed in vivo. In addition, our preliminary 
results demonstrated the ability of cryopreserved follicles to survive after in vitro culture. 
Toxicity testing revealed that all treatments had a toxic effect on caprine preantral 
follicles; there was a significant reduction in morphologically normal follicles. Cryoprotectants 
can chemically interact with important biomolecules in cells or tissues and exert toxic effects 
[34] if they are used in high [4] or inadequate concentrations. Besides concentration, 
temperature and duration of exposure to a certain cryoprotectant can also influence its 
toxicity [35]. Therefore, we suggest that the temperature (20 °C) and the time (20 min) of 
exposure used in the present study may not be appropriate for GLY and EG at the tested 
concentrations, since the percentage of morphologically normal preantral follicles was lower 
than for controls. The percentage of normal preantral follicles after cryopreservation was also 
significantly lower than in controls. However, that reduction had already been observed 
immediately after exposure to the cryoprotectant, indicating that cryopreservation was not 
the only factor responsible for the loss of follicular viability. Contrary to our findings, Hovatta 
et al. [14] observed no difference in the percentage of normal and atretic preantral follicles in 
human ovarian tissue before and after freezing. These results may be due to the differences 
between species, as well as to the cryopreservation protocol (type and time of exposure to 
cryoprotectant, slower freezing curve and a multistep process removal of cryoprotectant) 
used. The successful cryopreservation of oocytes has also been previously reported. Candy et 
al. [25], working with mouse oocytes, showed that the rate of maturation to metaphase II was 
not significantly different between frozen and fresh oocytes (83% versus 74%). Additionally, 
the in vitro fertilization rate was similar for frozen and fresh oocytes (70% versus 81%). In 
other studies, there was successful cryopreservation of oocytes of several species, with live 
births reported for mice [36], rabbits [37], and cows [1]. The success obtained in these 
experiments may be due to the cryopreservation protocols being more appropriate for the 
developmental stage of the oocytes and the preservation forms used (oocytes without 
cumulus cells), as well as to intrinsic characteristics of each species. 
With regard to the toxicity test, 3 M GLY and EG were more toxic to ovarian tissue than 
1.5 M. However, after cryopreservation, 3 M EG was more efficient at maintaining follicle 
integrity than 1.5 M EG, suggesting that 1.5 M EG provided less protection of caprine ovarian 
tissue against cryoinjury or thawing. A concentration of 3 M EG is probably more effective than 
1.5 M EG at reducing intracellular ice formation (IIF). The cryoprotectants diffuse across cell 
membranes in exchange for cell water. This displacement of water by cryoprotectants, in 
addition to freezing point depression, decreases the possibility of IIF and maintains cell volume 
during freezing, avoiding damage [38]. For caprine ovarian tissue, we speculate that a higher 
concentration of EG may be necessary. Toxicity testing also demonstrated that 1.5 and 3 M EG 
were more efficient than GLY (at the same concentrations) for maintaining normal morphology 
of the preantral follicles. However, after cryopreservation, the efficiency of these two 
cryoprotectants was similar. The present study demonstrated the importance of the toxicity 
test; it showed that exposure to cryoprotectants can have deleterious effects on ovarian 
tissues that can compromise the cryopreservation procedure. However, it also demonstrated 
that toxicity testing could not predict the ideal cryoprotectant and concentration for 
cryopreservation. Toxicity testing verified that 1.5 M EG was better than 3 M EG or 1.5 and 3 M 
GLY. After cryopreservation, alterations were intensified during the other phases of the 
cryopreservation process, but only at concentrations of 1.5 M EG; this may be due to the 
inadequacy of time (20 min), and temperature (20 °C) of exposure to 1.5 M EG, or the 
combination of those factors with the cooling rate used. 
In all treatments, from the toxicity test to after cryopreservation, the percentage of 
degenerated Grade 2 follicles was greater (P<0.05) than that of controls, demonstrating that 
the toxic effect of the cryoprotectant can be detrimental for both follicular compartments 
(oocyte and granulosa cells); this may be due to osmotic damage caused by GLY and EG. During 
exposure to cryoprotectants, cells initially lose water and shrink to compensate for the high 
extracellular osmolarity caused by the cryoprotectants [39]. Considering these normal events 
and the present results, we suggest that the concentrations of cryoprotectants, temperature 
and time of exposure tested were not optimal for caprine preantral follicles. 
When comparisons were performed between the cryoprotectants at both 
concentrations (1.5 M GLY×3 M EG and 3 M GLY×1.5 M EG), after toxicity testing the 
percentage of Grade 1 preantral follicles was significantly superior in 3 M GLY and EG when 
compared, respectively, to 1.5 M EG and GLY. On the contrary, after cryopreservation, 1.5 M 
GLY and EG were, respectively, more harmful than 3 M EG and GLY, indicating that for ovarian 
tissue needs a higher concentration of each cryoprotectant for cryopreservation, probably due 
to the occurrence of IIF. According to Mazur [40], the two main causes of cellular death during 
freezing and thawing are solution effects and IIF. 
Regarding the percentage of Grade 2 degeneration after toxicity testing, the rate was 
significantly higher for 1.5 and 3 M GLY when compared respectively, to 3 and 1.5 M EG. After 
cryopreservation, the percentage of degenerated Grade 2 follicles was also significantly 
greater for 3 M versus 1.5 M EG. On the other hand, the percentage of follicles with 
degeneration Grade 2 in 3 M EG was similar to that found for ovarian tissue cryopreserved in 
1.5 M GLY. Therefore, GLY was more toxic for ovarian tissue than EG. This may have been due 
to the low permeability of GLY; this could have increased osmotic stress during addition, 
thawing and removal of the cryoprotectant, since the influx of water is faster than the efflux of 
GLY from the cells [12] and [41]. 
The cryopreservation of ovarian tissue in 1.5 M GLY and EG resulted in a significant 
increase in the percentage of preantral follicles with Grade 1 degeneration when compared to 
the toxicity test. Therefore, to obtain a lower percentage of degenerated Grade 1 follicles, we 
could utilize a higher cryoprotectant concentration, although the percentage of normal 
preantral follicles, for both 1.5 and 3 M GLY, was similar. Similar results were observed for 
follicles with Grade 2 degeneration, in the presence of 1.5 and 3 M EG, for both toxicity testing 
and cryopreservation. These results may be due to ice crystal formation between follicular 
cells and within follicular cells and the oocyte. Sugimoto et al. [13] demonstrated that the 
formation of ice in the intercellular space could easily damage the cells and destroy cell–cell 
communication, which is essential to maintain tissue integrity. Ovarian tissue, like other 
tissues, is a complex system of organized cells that requires coordinated interactions between 
the cells and the extracellular matrix to maintain function [42]. Addition of cryoprotectant 
prior to cooling and its removal after warming involves coupled membrane transport of water 
and the cryoprotectant; if performed improperly, this can result in deleterious cell volume 
changes [43]. Some cell types are damaged by the cell shrinkage induced by cryoprotectant 
addition. However, cell swelling during removal of cryoprotectant is more likely to be 
deleterious [44]. 
The follicular degeneration (nuclear pyknosis and oocyte shrinkage) detected in the 
present study were also described by other authors after cryopreservation of human [14] and 
non-human primate ovarian tissue [11]. Additionally, the degeneration in the granulosa cell 
layer (detachment and disorganization) observed in our study has also been detected after 
vitrification of murine [13] and slow freezing of bovine [15] ovarian tissue. The system used to 
classify degenerated follicles (Grades 1 and 2) was similar to that described by Paynter et al. 
[15] for bovine degenerated follicles in cryopreserved ovarian tissue. However, there was an 
important difference between the classifications. In the present study, alterations in the 
granulosa cells of the main follicular category used (i.e. primordial follicles) were always 
accompanied by oocyte shrinkage and/or pyknosis. In contrast, Paynter et al. [15] used 
primary and secondary bovine follicles. This result may be due to the differences between 
species, as well as to the developmental stage of the follicles used in the cryopreservation 
procedure. 
Histology did not reveal qualitative differences between different cryoprotectants and 
concentrations in preantral follicles (soon after cryopreservation), except between 1.5 and 3 M 
EG. However, TEM revealed that follicles cryopreserved in 1.5 M EG had many signs of 
ultrastructural abnormality, such as the presence of numerous vacuoles in the oocyte 
cytoplasm. Hay et al. [45] and Assey et al. [46] demonstrated that cytoplasmic vacuoles are 
also a characteristic sign of degeneration in both granulosa and cumulus cells during 
degeneration in vivo. According to Fuku et al. [47], in bovine cryopreserved oocytes, these 
vacuoles may represent altered mitochondria. The ultrastructural analysis also demonstrated 
that the ultrastructural morphology of cryopreserved follicles in 3 M EG was better preserved 
than that of follicles cryopreserved in 1.5 M EG and GLY at both concentrations. Hovatta et al. 
[14] reported that histology is relatively uninformative if performed immediately after the 
thawing; sudden changes in the organelles can appear even several hours after thawing. 
Therefore, when TEM is not available, it is advisable to maintain the ovarian tissue in an 
incubator prior to fixation [14]. In addition, using different cryopreservation protocols from 
that used in the present study, others have demonstrated the inefficiency of GLY in the 
cryopreservation of female gametes [48] and [49]. Parrot [48] showed that 80% of the oocytes 
present in mice ovarian tissue were destroyed after exposure to 1.6 M GLY for 1.5 h at room 
temperature. In nonhuman primates (Rhesus and Cynomolgus monkeys) the deleterious effect 
of GLY was also demonstrated in cooling of immature oocytes. In these species, the actin 
filament system was distorted in oocytes exposed to 1.0 and 2.0 M GLY at 23 °C [49]. Previous 
work with mature caprine oocytes indicated that the permeability of GLY was highly 
dependent on temperature, and at 20 °C [4] and 4 °C [16], this cryoprotectant has lower 
permeability than EG. Newton et al. [18] compared the efficiency of four cryoprotectants 
(DMSO, propanediol, EG and GLY) in the cryopreservation of human ovarian tissue; they 
showed that EG had better results because it penetrated more quickly in the tissue, due 
probably to its lower molecular weight [50]. Based on the literature [12] and [16], EG was 
more effective at protecting cells during cryopreservation than GLY, perhaps due to its low 
toxicity and efficient permeability [51]. Although some authors [12], [16] and [18] have shown 
that GLY is inferior to the other cryoprotectants, in our study the percentage of normal 
preantral follicles after cryopreservation in GLY was similar to EG. It is noteworthy that we 
used a different slow freezing curve and a removal procedure for GLY similar to the employed 
by Candy et al. [12]. However, results obtained by Candy et al. [12] using GLY (4.3–28.3 and 
16.3–32%: survival of primordial and primary follicles, respectively) were comparable to those 
for caprine preantral follicles in our experimental conditions. Another report in human ovarian 
tissue [18] using a freezing protocol similar to Candy et al. [12], i.e. slow freezing curve and fast 
removal of GLY without sucrose, obtained only 10% viable preantral follicles after freezing and 
thawing. Similarly to Candy et al. [12] and Newton et al. [18], in the present study we used an 
initial cooling rate of 2 °C/min to the seeding temperature and a cooling rate of 0.3 °C/min 
from the seeding temperature (−7 °C in this experiment) to a lower temperature. However, 
unlike previous studies in which the ovary was cooled to −140 °C [18] or −150 °C [12] before 
storage in liquid nitrogen, in our study the ovarian tissue was cooled to −33 °C. According to 
Shaw et al. [52], although cells cooled in this way still contain some water when they are 
plunged into liquid nitrogen, there is not enough intracellular water to cause damage 
(providing that appropriate rapid warming protocols are used). However, the cryopreservation 
procedure used in this work might be improved by testing different freezing curves, removal 
procedures of cryoprotectan, and equilibration periods. 
In conclusion, we demonstrated that caprine preantral follicles in ovarian tissue can be 
cryopreserved using GLY and EG. Based on these results, cryopreservation of caprine ovarian 
tissue can be a feasible alternative for preservation of female genetic material, with the 
opportunity to subsequently restore ovarian activity via transplant and/or in vitro maturation 
of preantral follicles enclosed in the ovarian tissue. 
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